ROSWELL PARK CANCER INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Not Applicable

Recruiting

Conditions: Breast Carcinoma
Healthy Subject

Interventions: Procedure: Photoacoustic Imaging

First Posted Date: 2019-04-01

Last Posted Date: 2024-11-04

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 320

Registration Number: NCT03897270

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Experimental Tobacco Marketplace in Regulating Flavored Tobacco Products in Menthol Cigarette Smokers

Not Applicable

Terminated

Conditions: Cigarette Smoking

Interventions: Behavioral: Smoking Cessation Intervention
Other: Functional Assessment
Other: Questionnaire Administration

First Posted Date: 2019-04-01

Last Posted Date: 2024-04-03

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 103

Registration Number: NCT03897530

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients

Not Applicable

Completed

Conditions: Hematologic and Lymphocytic Disorder
Malignant Neoplasm
Parent
Guardian

Interventions: Other: Educational Activity
Procedure: Patient Monitoring
Other: Questionnaire Administration

First Posted Date: 2019-03-29

Last Posted Date: 2021-09-16

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 9

Registration Number: NCT03895918

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation

Phase 2

Withdrawn

Conditions: Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level
Blasts Under 5 Percent of Peripheral Blood White Cells
IDH2 Gene Mutation
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia

Interventions: Drug: Enasidenib
Procedure: Hematopoietic Cell Transplantation

First Posted Date: 2019-03-19

Last Posted Date: 2021-03-10

Lead Sponsor: Roswell Park Cancer Institute

Registration Number: NCT03881735

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸
Cancer Institute at St Francis Hosptial, East Hills, New York, United States

Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors

Not Applicable

Recruiting

Conditions: Stage A Prostate Cancer
Stage III Prostate Cancer
Stage IIIB Prostate Cancer
Stage IV Prostate Cancer
Obesity
Stage C Prostate Cancer
Stage II Prostate Cancer
Stage IIB Prostate Cancer
Stage IIC Prostate Cancer
Stage IIIA Prostate Cancer

Interventions: Dietary Supplement: Dietary Intervention
Other: Educational Intervention
Behavioral: Exercise Intervention
Other: Quality-of-Life Assessment
Other: Survey Administration

First Posted Date: 2019-03-19

Last Posted Date: 2024-06-04

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 30

Registration Number: NCT03880422

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Phase 1

Recruiting

Conditions: Lung Atypical Carcinoid Tumor
Metastatic Pancreatic Neuroendocrine Tumor
Lung Typical Carcinoid Tumor

Interventions: Biological: Incomplete Freund's Adjuvant
Drug: Octreotide Acetate
Biological: Sargramostim
Biological: SVN53-67/M57-KLH Peptide Vaccine

First Posted Date: 2019-03-19

Last Posted Date: 2024-12-18

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 14

Registration Number: NCT03879694

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers

Not Applicable

Recruiting

Conditions: Current Every Day Smoker
Cigarette Smoker
Current Smoker

Interventions: Other: Questionnaire Administration
Procedure: Sham Intervention
Procedure: Repetitive Transcranial Magnetic Stimulation

First Posted Date: 2019-03-07

Last Posted Date: 2024-03-22

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 300

Registration Number: NCT03865472

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Phase 1

Withdrawn

Conditions: CD22 Positive
Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells
Recurrent B Acute Lymphoblastic Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Blasts 5 Percent or More of Peripheral Blood White Cells
Lymphoblasts 20 Percent or More of Peripheral Blood White Cells
Refractory B Acute Lymphoblastic Leukemia
Blasts 5 Percent or More of Bone Marrow Nucleated Cells

Interventions: Biological: Inotuzumab Ozogamicin
Other: Quality-of-Life Assessment
Drug: Vincristine Sulfate Liposome

First Posted Date: 2019-02-22

Last Posted Date: 2022-01-28

Lead Sponsor: Roswell Park Cancer Institute

Registration Number: NCT03851081

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma

Not Applicable

Completed

Conditions: Plasma Cell Myeloma

Interventions: Device: FitBit
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Other: Resistance Training
Behavioral: STEPS to Enhance Physical Activity

First Posted Date: 2019-01-04

Last Posted Date: 2023-04-10

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 65

Registration Number: NCT03793907

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity

Not Applicable

Completed

Conditions: Cancer Survivor
Invasive Breast Carcinoma

Interventions: Other: Physical Activity
Other: Questionnaire Administration
Procedure: Repetitive Transcranial Magnetic Stimulation
Procedure: Sham Intervention

First Posted Date: 2018-12-31

Last Posted Date: 2021-10-26

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 30

Registration Number: NCT03789877

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy